
In a research report, Nomura lowered its revenue forecasts for WUXI APPTEC (02359.HK) +0.100 (+0.345%) Short selling $4.44M; Ratio 4.672% by 5.3% and 4.9% for this year and next respectively, and its profit forecasts by 4.4% and 3.1%, taking into account geopolitical uncertainties arising from the Biosecure Act at the US House of Representatives, as well as the potential negative impact of the weak domestic financing environment on the company's outlook for new orders and existing orders.
Nomura dropped WUXI APPTEC's target price from $54.56 to $43.45 and maintained its Buy rating. The broker also recommended investors to closely monitor the latest progress of the US Biosecure Act and its related impacts.
Related NewsCICC: Re-entry Into High Div. Theme Should Wait Until Sufficient Pullback; Prefers Semiconductors/ Autos/ Medias/ Softwares/ Biotechs in Short Term
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-07-23 16:25.)
AAStocks Financial News
Promoting the development of lithium and sodium in the new energy industry
More than 20 A-share companies will be at risk of delisting!
Is Xiaohongshu's major shareholder selling shares valued at 20 billion?
TikTok "refugees" move to Xiaohongshu. How long will this craze last?
Check whenever you want
WikiStock APP